drugset / Trial / NCT01476215

A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

NCT01476215

Phase 1 Completed 18 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-label

Summary

This proof of principle PK study will allow GSKCH to select the most favorable sustained release formulation among 3 prototypes to move to the next stage of drug development.

Timeline

Start
2009-11
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule

Indications

No indication recorded.